About: Angiotech Pharmaceuticals

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.

Property Value
dbo:abstract
  • Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins. In 2017, Angiotech was acquired by a consortium led by the U.S. healthcare investment firm Vivo Capital and China's ZQ Capital. (en)
dbo:industry
dbo:numberOfEmployees
  • 1450 (xsd:nonNegativeInteger)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 875678 (xsd:integer)
dbo:wikiPageLength
  • 2546 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1026558485 (xsd:integer)
dbo:wikiPageWikiLink
dbp:homepage
dbp:industry
  • Pharmaceutical (en)
dbp:keyPeople
  • K. Thomas Bailey (en)
dbp:locationCity
dbp:locationCountry
dbp:name
  • Angiotech Pharmaceuticals Inc (en)
dbp:numEmployees
  • 1450 (xsd:integer)
dbp:type
  • Public (en)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins. (en)
rdfs:label
  • Angiotech Pharmaceuticals (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Angiotech Pharmaceuticals Inc (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License